RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 142 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $192,046 | +224.2% | 177,820 | +287.3% | 0.00% | – |
| Q2 2023 | $59,228 | -35.2% | 45,913 | -33.7% | 0.00% | – |
| Q1 2023 | $91,411 | -39.5% | 69,251 | -31.2% | 0.00% | – |
| Q4 2022 | $150,984 | -99.9% | 100,656 | +5.0% | 0.00% | – |
| Q3 2022 | $113,065,000 | +177.7% | 95,818 | +165.9% | 0.00% | – |
| Q2 2022 | $40,721,000 | -2.3% | 36,036 | +158.5% | 0.00% | – |
| Q1 2022 | $41,681,000 | -54.5% | 13,940 | -59.6% | 0.00% | – |
| Q4 2021 | $91,520,000 | -16.6% | 34,536 | +14.2% | 0.00% | – |
| Q3 2021 | $109,771,000 | +290.0% | 30,240 | +366.3% | 0.00% | – |
| Q2 2021 | $28,145,000 | -79.1% | 6,485 | -83.6% | 0.00% | – |
| Q1 2021 | $134,987,000 | +86.8% | 39,470 | +91.2% | 0.00% | – |
| Q4 2020 | $72,244,000 | -28.6% | 20,641 | -51.1% | 0.00% | – |
| Q3 2020 | $101,225,000 | +841.2% | 42,177 | +617.7% | 0.00% | – |
| Q2 2020 | $10,755,000 | -86.7% | 5,877 | -88.6% | 0.00% | – |
| Q1 2020 | $80,686,000 | +95.1% | 51,722 | +167.6% | 0.00% | – |
| Q4 2019 | $41,366,000 | -17.3% | 19,330 | -27.7% | 0.00% | – |
| Q3 2019 | $50,017,000 | +3.3% | 26,747 | +44.1% | 0.00% | – |
| Q2 2019 | $48,431,000 | -46.1% | 18,556 | -46.9% | 0.00% | – |
| Q1 2019 | $89,801,000 | +884.2% | 34,942 | +780.8% | 0.00% | – |
| Q4 2018 | $9,124,000 | -67.5% | 3,967 | -54.7% | 0.00% | – |
| Q3 2018 | $28,088,000 | +13.4% | 8,750 | 0.0% | 0.00% | – |
| Q2 2018 | $24,762,000 | -77.1% | 8,750 | -71.4% | 0.00% | – |
| Q1 2018 | $108,151,000 | -7.2% | 30,551 | +1.7% | 0.00% | – |
| Q4 2017 | $116,547,000 | +385.0% | 30,038 | +217.5% | 0.00% | – |
| Q3 2017 | $24,028,000 | -27.7% | 9,460 | -22.3% | 0.00% | – |
| Q2 2017 | $33,235,000 | +130.0% | 12,174 | +178.8% | 0.00% | – |
| Q1 2017 | $14,451,000 | +276.4% | 4,366 | +170.7% | 0.00% | – |
| Q4 2016 | $3,839,000 | -83.9% | 1,613 | -75.2% | 0.00% | – |
| Q3 2016 | $23,877,000 | +196.2% | 6,506 | +80.0% | 0.00% | – |
| Q2 2016 | $8,061,000 | -84.3% | 3,615 | -78.6% | 0.00% | – |
| Q4 2015 | $51,220,000 | +10.5% | 16,904 | -9.9% | 0.00% | – |
| Q3 2015 | $46,354,000 | +96.9% | 18,767 | +155.9% | 0.00% | – |
| Q2 2015 | $23,539,000 | +218.7% | 7,333 | +254.4% | 0.00% | – |
| Q1 2015 | $7,386,000 | -26.7% | 2,069 | -60.2% | 0.00% | – |
| Q3 2014 | $10,078,000 | +212.9% | 5,195 | +359.7% | 0.00% | – |
| Q4 2013 | $3,221,000 | -96.2% | 1,130 | -95.3% | 0.00% | – |
| Q3 2013 | $85,183,000 | -11.9% | 23,794 | -17.8% | 0.00% | – |
| Q2 2013 | $96,696,000 | – | 28,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
| Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
| Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
| Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
| ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
| SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
| Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
| NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
| Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |